Trial design and end points in hepatocellular carcinoma: an EASL–AASLD–ILCA consensus statement

作者：Josep Maria Llovet, Ezequiel Mauro, Lorenza Rimassa, Vincenzo Mazzaferro, Matthias Pinter, Robin Kate Kelley, Stephen L. Chan, Laura Kulik, Anjana Pillai, Lewis Rowland Roberts, Bruno Sangro, Teresa Casanovas, David Edward Kaplan, Arndt Vogel, Mark M. Yarchoan, Richard S. Finn, Tim Meyer, Amit G. Singal · 发表于：Nature Reviews Clinical Oncology · 年份：2026 · DOI：10.1038/s41571-026-01160-z · 被引用次数：5 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Liver physiology and pathology、Cancer Mechanisms and Therapy